2010
DOI: 10.1089/end.2009.0483
|View full text |Cite
|
Sign up to set email alerts
|

Randomized Comparison of Efficacy of Paracetamol, Lornoxicam, and Tramadol Representing Three Different Groups of Analgesics for Pain Control in Extracorporeal Shockwave Lithotripsy

Abstract: This study suggests that paracetamol, lornoxicam, and tramadol can be safely and efficiently preferred in pain control during SWL.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
38
0
1

Year Published

2011
2011
2019
2019

Publication Types

Select...
6
1

Relationship

0
7

Authors

Journals

citations
Cited by 26 publications
(39 citation statements)
references
References 19 publications
0
38
0
1
Order By: Relevance
“…Our assessment identified 9 studies that involved 539 participants (from 6 countries) which were available for inclusion dating from years 1992 to 2010 (25-33). One of these studies had multiple treatment arms (25).…”
Section: Included Studiesmentioning
confidence: 99%
See 3 more Smart Citations
“…Our assessment identified 9 studies that involved 539 participants (from 6 countries) which were available for inclusion dating from years 1992 to 2010 (25-33). One of these studies had multiple treatment arms (25).…”
Section: Included Studiesmentioning
confidence: 99%
“…One of these studies had multiple treatment arms (25). Trial agents included seven types of NSAIDs (lornoxicam, piroxicam, diclofeanc, keterolac, parecoxib, indomethacin and dexketoprofen), one simple analgesic (paracetamol) and five types of opioids (tramadol, remifentanil, fentanyl and morphine and pethidine).…”
Section: Included Studiesmentioning
confidence: 99%
See 2 more Smart Citations
“…Its short half-elimination time (4 hours regardless of the drug concentration) makes side effects less significant, because during the period between drug administration the renewal of physiological levels of prostaglandins required for protection of the gastric mucosa from the damage takes its place. Xefocam is recommended for treatment of extreme and chronic inflammatory states and associated pathological processes and pain [10].…”
mentioning
confidence: 99%